141 related articles for article (PubMed ID: 32211850)
21. Dysregulation of DNA methylation induced by past arsenic treatment causes persistent genomic instability in mammalian cells.
Mauro M; Caradonna F; Klein CB
Environ Mol Mutagen; 2016 Mar; 57(2):137-50. PubMed ID: 26581878
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer.
Hsu HS; Wen CK; Tang YA; Lin RK; Li WY; Hsu WH; Wang YC
Clin Cancer Res; 2005 Aug; 11(15):5410-6. PubMed ID: 16061855
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
24. The profile of hMLH1 methylation and microsatellite instability in colorectal and non-small cell lung cancer.
Okuda T; Kawakami K; Ishiguro K; Oda M; Omura K; Watanabe G
Int J Mol Med; 2005 Jan; 15(1):85-90. PubMed ID: 15583832
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in hMSH2 and hMLH1 and response to platinum-based chemotherapy in advanced non-small-cell lung cancer patients.
Cheng H; Sun N; Sun X; Chen B; Li F; Feng J; Cheng L; Cao Y
Acta Biochim Biophys Sin (Shanghai); 2010 May; 42(5):311-7. PubMed ID: 20458443
[TBL] [Abstract][Full Text] [Related]
26. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
[TBL] [Abstract][Full Text] [Related]
27. [Study the value of screening hereditary nonpolyposis colorectal cancer kindreds by detecting the expression of hMLH1/hMSH2 with tissue microarray].
Jin HY; Ding YJ; Geng JX; Liu F; Yang BL; Huang SL; Ding SQ; Ge YS
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):67-9. PubMed ID: 17253179
[TBL] [Abstract][Full Text] [Related]
28. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
[TBL] [Abstract][Full Text] [Related]
29. The Association Between
Xing Z; Guo G; Pan X; Xu L; Guo C; An R
Genet Test Mol Biomarkers; 2019 Aug; 23(8):573-579. PubMed ID: 31373852
[No Abstract] [Full Text] [Related]
30. Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.
Fang JY; Cheng ZH; Chen YX; Lu R; Yang L; Zhu HY; Lu LG
World J Gastroenterol; 2004 Dec; 10(23):3394-8. PubMed ID: 15526354
[TBL] [Abstract][Full Text] [Related]
31. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.
Suzuki M; Sunaga N; Shames DS; Toyooka S; Gazdar AF; Minna JD
Cancer Res; 2004 May; 64(9):3137-43. PubMed ID: 15126351
[TBL] [Abstract][Full Text] [Related]
32. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability.
Bevilacqua RA; Simpson AJ
Int J Cancer; 2000 Jul; 87(2):200-3. PubMed ID: 10861474
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity combined with promoter hypermethylation, the main mechanism of human MutL Homolog (hMLH1) gene inactivation in non-small cell lung cancer in a Chinese population.
Geng X; Wang F; Zhang L; Zhang WM
Tumori; 2009; 95(4):488-94. PubMed ID: 19856662
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1.
Shin KH; Park JG
Eur J Cancer; 2000 May; 36(7):925-31. PubMed ID: 10785599
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells.
Zhong Z; Dong Z; Yang L; Chen X; Gong Z
Tumour Biol; 2013 Jun; 34(3):1959-65. PubMed ID: 23539435
[TBL] [Abstract][Full Text] [Related]
36. Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers.
Yuen ST; Chan TL; Ho JW; Chan AS; Chung LP; Lam PW; Tse CW; Wyllie AH; Leung SY
Oncogene; 2002 Oct; 21(49):7585-92. PubMed ID: 12386821
[TBL] [Abstract][Full Text] [Related]
37. [Expression and significance of mismatch repair genes hMLH1 and hMSH2 in sporadic colorectal carcinoma].
Zheng JY; Ren TS; Liu B; Wang MN; Liao HH
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):590-4. PubMed ID: 21122410
[TBL] [Abstract][Full Text] [Related]
38. Methylation of hMLH1 in a population-based series of endometrial carcinomas.
Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S
Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752
[TBL] [Abstract][Full Text] [Related]
39. Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.
Kondo E; Furukawa T; Yoshinaga K; Kijima H; Semba S; Yatsuoka T; Yokoyama T; Fukushige S; Horii A
Int J Oncol; 2000 Sep; 17(3):535-41. PubMed ID: 10938395
[TBL] [Abstract][Full Text] [Related]
40. Aberrant methylation of DNA mismatch repair genes in elderly patients with sporadic gastric carcinoma: A comparison with younger patients.
Kim HG; Lee S; Kim DY; Ryu SY; Joo JK; Kim JC; Lee KH; Lee JH
J Surg Oncol; 2010 Jan; 101(1):28-35. PubMed ID: 19894224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]